Events

A new generation of human model systems are coming to the forefront of drug development, including novel organoid, microphysiological and in silico platforms. With the passage of the FDA Modernization Act 2.0 in 2022, these cutting-edge systems are poised to gain increasing scientific, commercial and regulatory acceptance in replacing data traditionally sought from animal models. But how far can these systems go in displacing animals, and what commercial and regulatory challenges stand in their path?

Join us as we convene a panel of experts in alternative human model systems to discuss their changing role in science and business. 

Panelists:
•    Lowry Curley, Ph.D., Co-Founder and CEO of Axosim
•    Krista Durney, Ph.D., Associate Director, Innovation & Business Development at Valo Health
•    Kristin Bircsak, Ph.D., Principal Scientist at MIMETAS
•    Iris Bica, Business Development & Licensing Associate at Weill Cornell Medicine (Moderator)

Center for Technology Licensing (CTL) at Weill Cornell Medicine Office Hours are open to all who wish to gain more information about the advancement of their patent filings and to discuss their technology venture project with a one-on-one meeting with a Weill Cornell Business Development and Licensing Officer.

The May 16th office hours will be hosted by James Bellush, Ph.D, Manager of Scientific Scouting. James is a trained molecular biologist with 10+ years of life sciences experience, specifically focused on drug development, biotech investing, and startup company operations. Before joining the CTL at Weill Cornell team, he was leading scientific diligence, preclinical development, commercial analysis and alliance management for a New York City based biotech venture capital firm. In his current role, James supports a broad portfolio of translational research projects at Weill Cornell through various mechanisms which include sourcing external funding opportunities, establishing biopharma research collaborations and helping advance drug candidates to partnership-ready stages.

Register here for your 30-minute private session with James. 

Led by the NSF I-Corps Hub: Interior Northeast (IN I-Corps), these free NSF I-Corps Regional Courses are designed for university-based STEM researchers and early-stage founders interested in evaluating the market potential of their technology and learning valuable entrepreneurial skills

In this month-long, virtual course (June 10 - July 10), researchers working on a deep tech innovation “get out of your comfort zone” and talk with customers (virtually) to identify the best product-market fit.

Apply now. Application closes on Wednesday, May 15. Questions? Contact icorps@cornell.edu or visit www.in-icorps.org/regional-courses. 

The BioVenture eLab, a part of Weill Cornell Medicine Enterprise Innovation, invites you to learn about how Weill Cornell Medicine faculty entrepreneurs can take advantage of the $100K Biomedical Business Plan Challenge accelerator.

Join our virtual event to hear from two featured entrepreneurs who have participated in the Business Plan Challenge accelerator.

You'll learn specifically how the accelerator helped these successful founders:

• Create their initial business plans
• Form relationships with advisors & service providers
• Advance their projects with introductions to grant writers and financing sources

The panel features:

Evi Giannakakou, PhD - Professor of Pharmacology in Medicine Weill Cornell Medicine; Co-Founder of ARMA Bio

Marc Schiffman, MD - Assistant Professor of Clinical Research, Radiology Weill Cornell Medicine; Co-Founder of VoiceLove LLC

Calling all researchers! If you have been working on a technology innovation and wish to explore its commercialization potential, I-Corps can provide you with entrepreneurial education, mentoring, and up to $50,000 in funding for customer discovery.   

Hosted by the Interior Northeast I-Corps Hub (IN I-Corps), the virtual NSF I-Corps Information Session is designed for busy graduate students, postdocs, and faculty interested in learning more about I-Corps regional and national programming. I-Corps instructors and alumni will be in attendance to share their experiences and answer questions. 

The National Science Foundation created I-Corps (Innovation Corps) to bridge the gap between fundamental research discoveries in science and engineering and the commercialization of technologies, products, and processes with the potential to benefit society.  

Register here.   

Calling pre-seed and seed innovators and entrepreneurs in Oncology, Cell & Gene Therapy, Cardiovascular, Immunology, Radiology, and Digital Health!

Do you have disruptive science but struggle to bring it to life in the entrepreneurial world? Bayer's passion is to enable and support standout healthcare innovation.

Take your innovation to new heights and join Bayer's Expert Mondays 2024, a series of knowledge exchange sessions to supercharge your startup’s growth.

Each one-hour Bayer's Expert Monday includes a live Q&A with respective Bayer Experts. You can stay for a Meet & Greet with Bayer Scouts and Scientific Finders. Please reserve 30 additional minutes in your schedule for the Meet & Greet after the Bayer Expert session.

These sessions are not intended for service providers, consultants, IT providers, etc. They are designed for drug developers and healthcare researchers seeking collaboration with big pharma and out-licensing opportunities later in their journey. Session recordings are NOT distributed afterward. Live attendance is necessary to get the most out of the expert sessions and network with the Bayer Pharma team.

The May 13 event features Dr. Isabelle Stoeckert, VP, Head RA EMEA, Dr. Gabriele Bräunlich, VP, RA EMEA, Head RA Strategy, and Dr. Jana Napolitano, RA Strategy, New Modalities. Reserve your spot here. 

Friends of Cancer Research (Friends) and the Parker Institute for Cancer Immunotherapy (PICI) are proud to announce our upcoming joint public meeting, Unlocking Complex Cell-based Gene Therapies. Discussions among key stakeholders at the meeting will enable the next generation of proposals in the rapidly changing cell and gene therapy space, reimagining trials and treatments for patients.

See meeting agenda and register here. Please note that this meeting has a virtual admission option. After you fill out the first page of required information, click to the next page where you confirm your information as an attendee and select the virtual option at the bottom prior to submitting the registration. 

BioVenture eLab, a part of Weill Cornell Medicine Enterprise Innovation, invites you to an interview with Dr. Elizabeth Comen, author and breast cancer oncologist at Memorial Sloan Kettering Cancer Center and assistant professor of medicine at Weill Cornell Medical College. This program is being hosted in collaboration with Women in Bio (WIB-Metro New York).

Join us for an interactive session with Dr. Comen highlighting her book "All In Her Head: The Truth and Lies Early Medicine Taught Us About Women’s Bodies and Why It Matters Today", an eye-opening account of medical history that is both a collective narrative of women’s bodies and experiences as well as a call to action for a new conversation around women’s health. The interview will be moderated by Dr. Lucia Regales, senior director of oncology clinical sciences at Curis.

Dr. Comen has appeared on "Good Morning America", "The Today Show", "The View", ABC News, NY1, Wall Street Journal online, Fox News and other news and print outlets, such as The New York Times, Today.com, Elle magazine, and Self magazine and is a well-known advocate in women's healthcare issues.

The event will be in-person at the BioVenture eLab space located at 1157 York Ave (between 62nd and 63rd St). Light snacks and beverages will be served and the event will feature a networking session with Women in Bio members and NYC life science industry representatives.

RSVP here. Registration is free for WIB members and $15 for non-members.

Now more than ever, we need deep tech solutions to address complex systemic problems facing society. Join this virtual workshop to meet and learn from entrepreneurs who are tackling these challenges. You’ll find out how they got off the ground and worked together within their sociotechnical ecosystems to make it happen.

Andrea Ippolito, founder of the baby-feeding support startup Simplifed and director of W.E. Cornell, will lead the session. She’ll be joined by panelists Dr. Katherine Saunders, co-founder of Intellihealth, and Brad Hartwig, CEO of Arbor.

Register here. Questions? Contact crea@cornell.edu.

In this month-long, virtual course (May 27 - June 26), deaf and hard of hearing researchers working on a deep tech innovation “get out of your comfort zone” and talk with customers (virtually) to identify the best product-market fit. 

Register now. Application closes on Wednesday, May 1.